AI-based gastroscopy real-time lesion tracking scene

[View original text]

Partnership discussions with Japanese partners are in full swing, and overseas expansion will be introduced soon

AIDOT (CEO Jae-hoon Jeong) announced that its artificial intelligence-based gastroscopy reading system has been approved for a clinical trial plan by the Ministry of Food and Drug 

Safety as a “Stomach cancer image detection diagnostic aid software.”

AIDOT's artificial intelligence-based gastroscopy solution was developed with a team led by Professor Chang-seok Bang of the Department of Gastroenterology at Hallym University 

Chuncheon Sacred Heart Hospital. The solution classified gastroscopy photos into 6 severity categories of △ Non-neoplasm △ LGD △ LGD △ HGD △ EGC(M) △ EGC(SM) △ AGC, 

and as a result of its own clinical evaluation, overall sensitivity and specificity by severity were 91.48% and 92.13%, respectively.

In addition, AIDOT said that it is an optimal diagnosis assistance system that immediately displays the location of suspected lesions based on real-time video during gastroscopy, so 

that doctors can receive help right away at the site of the procedure.

AIDOT's PIC saying that "As for existing gastroscopy equipment, equipment from specific countries and companies accounts for 80% of the global market share." also said "In this 

semi-exclusive environment, AIDOT introduces an artificial intelligence solution in the form of an integrated package that combines hardware and software that is simpler and more 

optimized for the compatibility of multiple image formats and ports of existing gastroscopy equipment. We are in the midst of discussions on solution purchase and strategic 

partnership with a Japanese partner called "the origin of gastroscopy equipment."

Yoon-jae Lim, head of Business Planning Headquarters, who handls Aidot's overall RA said, “The approval of the clinical protocol by the Ministry of Food and Drug Safety in Korea 

served as an opportunity to acknowledge the globalization of artificial intelligence gastroscopy solutions that have not been available in the global market until now.” “Through this 

clinical trial, We plan to complete licensing with excellent results, and we plan to complete the licensing process for colonoscopy and capsule endoscopy solutions, which have 

already been developed, soon to introduce an integrated solution in the field of fire extinguishers.”

Overview of AIDOT Inc.

Since its foundation in June 2014, AIDOT has been recognized for its technological prowess, including being selected for KIC China and various government projects. In addition, an 

artificial intelligence-based reading system combining carotid ultrasound and genomic information was jointly developed with Hallym University Chuncheon Sacred Heart Hospital's 

Department of Neurosurgery, and a digestive AI diagnosis system that integrated gastroscopy, capsule endoscopy, and colonoscopy was also completed.

Website: http://www.aidot.ai

07th.Sep.2022 / Newswire